Listed Company Update | AJJ Medtech (SGX: 584) Secures Institutional Supply Contract
$AJJ Medtech(584.SG)
AJJ Medtech announced a new institutional medical supply contract worth approximately S$3 million, covering biodegradable medical consumables. The contract starts on 1 June 2026, with an initial 2-year term and an extension option, while the company’s cumulative institutional revenue pipeline now exceeds S$8 million.
[AI-readable]
Company: AJJ Medtech Holdings Limited
Ticker: SGX: 584
Announcement Date: 9 March 2026
Announcement Title: AJJ Medtech Secures S$3M Institutional Contract for Biodegradable Medical Consumables
Contracting Entity: AJJ Healthcare Management Pte. Ltd. (wholly owned subsidiary)
Customer Type: A network of Singapore healthcare institutions
Contract Value: Approximately S$3 million
Product Category: Biodegradable medical consumables
Commencement Date: 1 June 2026
Contract Term: Initial two-year term with an option to extend for a further two years
Institutional Revenue Pipeline: Exceeds S$8 million
Financial Impact: Not expected to have a material impact on current financial year NTA or EPS; expected to contribute positively over the contract tenure.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
